- 1. (+)-(S)-4,4'-(1-Methyl-1,2-ethanediyl)di(2,6-piperazinedione)
- [A drug used to protect the heart from the toxic effects of anthracycline drugs such as doxorubicin. It belongs to the family of drugs called chemoprotective agents. ( NCI )] (UMLS (NCI) C0086444) =Organic Chemical; Pharmacologic Substance ;
=Razoxane;
[CV900] CARDIOVASCULAR AGENTS, OTHER =Dexrazoxane Hydrochloride;
| - 51. Small Intestinal Submucosa
- [Loose, filamentous areolar connective tissue between the muscularis mucosa and the muscular coat of the small intestine. It contains blood vessels, lymphatics, and nerves. The duodenal submucosa contains mucus-secreting Brunner's glands. ( NCI )] (UMLS (NCI) C0227268) =Tissue
|
- 2. (15S)-15-Methylprostaglandin F(sub 2alpha) Tromethamine
- [A synthetic 15-methyl analogue of the naturally occurring prostaglandin F2alpha. Carboprost tromethamine induces myometrium smooth muscle contraction by binding to the prostaglandin F2alpha receptors. This drug can be used to induce contractions to end pregnancy or to induce labour and to control severe postpartum bleeding. Due to its contractile effects on gastrointestinal smooth muscle, carboprost tromethamine can cause vomiting and diarrhea. ( NCI )] (UMLS (NCI) C0054721) =Organic Chemical; Pharmacologic Substance ;
| - 52. Small Intestinal Vasoactive Intestinal Peptide Producing Neoplasm
- (UMLS (NCI) C1336009) Small Intestinal Vasoactive Intestinal Peptide Producing Tumor;
Small Intestinal VIP Producing Neoplasm;
Small Intestinal VIP Producing Tumor;
Small Intestinal VIPoma =Neoplastic Process |
- 3. (2S)-2-Methylbutanoic Acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester
- [HMG coA reductase inhibitor which inhibits cholesterol biosynthesis and thus lowers blood cholesterol levels; also blocks isoprenylation of protein CAAX motifs. ( CSP )] (UMLS (NCI) C0024027) =Organic Chemical; Pharmacologic Substance ;
=antihypercholesterolemic agent;
[CV350] ANTILIPEMIC AGENTS;
naphthalene;
=[1S-[1alpha,3alpha,7beta,8beta(2S*,4S*),8abeta]]-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl 2,2-dimethylbutanoate;
LOVASTATIN 10 MG;
LOVASTATIN 20 MG;
LOVASTATIN 40 MG;
| - 53. Small Intestine Cancer Stage 0
- (UMLS (NCI) C0686083) =Neoplastic Process
|
- 4. (9S)-6'-Methoxycinchonan-9-ol Sulfate (2:1) (salt)
- [The sulfate salt form of quinidine, an alkaloid with antimalarial and antiarrhythmic (Class la) properties. Quinidine sulfate exerts its anti-malarial activity by acting primarily as an intra-erythrocytic schizonticide through association with the hemepolymer (hemozoin) in the acidic food vacuole of the parasite thereby preventing further polymerization by heme polymerase enzyme. This results in accumulation of toxic heme and death of the parasite. Quinidine sulfate exerts its antiarrhythmic effects by depressing the flow of sodium ions into cells during phase 0 of the cardiac action potential, thereby slowing the impulse conduction through the atrioventricular (AV) node, reducing the rate of phase 0 depolarization and prolonging the refractory period. Quinidine sulfate also reduces the slope of phase 4 depolarization in Purkinje-fibres resulting in slowed conduction and reduced automaticity in the heart. ( NCI )] (UMLS (NCI) C0034415) =Organic Chemical; Pharmacologic Substance ;
=QUINIDINE;
9S-6'-Methoxy-cinchonan-9-ol, Mono-D-gluconate(salt);
quinidine polygalacturonate;
=QUINIDINE SULFATE 200 MG;
QUINIDINE SULFATE 100 MG;
QUINIDINE SULFATE 300 MG | - 54. Small Intestine Cancer Stage I
- (UMLS (NCI) C1167735) Stage I Small Intestinal Cancer;
Stage I Small Intestine Carcinoma;
=Neoplastic Process |
- 5. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
- [potent and specific inhibitor of peptidyl dipeptidase A; it acts to suppress the renin-angiotensin system and inhibits blood pressure responses to exogenous angiotensin. ( CSP )] (UMLS (NCI) C0006938) =Amino Acid, Peptide, or Protein; Pharmacologic Substance =Amino Acids, Cyclic;
[CV800] ACE INHIBITORS;
PROLINE;
=CAPTOPRIL 100 MG;
CAPTOPRIL 12.5 MG;
CAPTOPRIL 25 MG;
CAPTOPRIL 50 MG;
| - 55. Small Intestine Cancer Stage II
- (UMLS (NCI) C1167736) Stage II Small Intestinal Cancer;
Stage II Small Intestine Carcinoma;
=Neoplastic Process |
- 6. 153Sm-EDTMP
- (UMLS (NCI) C0772051) Samarium Sm 153 Lexidronam;
Samarium Sm-153 EDTMP;
Samarium-153 EDTMP;
Samarium-153 Ethylenediaminetetramethylenephosphonate;
Samarium-153 Ethylenediaminetetramethylenephosphonic Acid;
Sm-153 EDTMP =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid | - 56. Small Intestine Cancer Stage III
- (UMLS (NCI) C1167737) Stage III Small Intestinal Cancer;
Stage III Small Intestine Carcinoma;
=Neoplastic Process |
- 7. 9S-6'-Methoxy-cinchonan-9-ol, Mono-D-gluconate(salt)
- [The gluconate salt form of quinidine, an alkaloid with antimalarial and antiarrhythmic (Class la) properties. Quinidine gluconate exerts its anti-malarial activity by acting primarily as an intra-erythrocytic schizonticide through association with the hemepolymer (hemozoin) in the acidic food vacuole of the parasite thereby preventing further polymerization by heme polymerase enzyme. This results in accumulation of toxic heme and death of the parasite. Quinidine gluconate exerts its antiarrhythmic effects by depressing the flow of sodium ions into cells during phase 0 of the cardiac action potential, thereby slowing the impulse conduction through the atrioventricular (AV) node, reducing the maximal rate of phase 0 depolarization and prolonging the refractory period. Quinidine gluconate also reduces the slope of phase 4 depolarization in Purkinje-fibres resulting in slowed conduction and reduced automaticity in the heart. ( NCI )] (UMLS (NCI) C0072869) =Organic Chemical; Pharmacologic Substance =QUINIDINE;
=(9S)-6'-Methoxycinchonan-9-ol Sulfate (2:1) (salt);
QUINIDINE GLUCONATE 80 MG/ML;
QUINIDINE GLUCONATE 324 MG | - 57. Small Intestine Cancer Stage IV
- (UMLS (NCI) C1167738) Stage IV Small Intestinal Cancer;
Stage IV Small Intestine Carcinoma;
=Neoplastic Process |
- 8. Sm Protein
- [The 4 major small nuclear ribonucleoprotein particles (snRNPs), U1, U2, U4/U6, and U5, are essential components of the eukaryotic pre-mRNA splicing machinery. These snRNPs share 8 proteins which form the snRNP structural core: SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF, and SNRPG. These common proteins play an essential role in the biogenesis of the snRNPs. The assembly of the common proteins onto the small nuclear RNA (snRNA) appears to occur in at least 2 steps and involves the formation of RNA-free protein heterooligomers. The common proteins are referred to as Sm proteins because they represent the major targets for the anti-Sm autoantibodies which are diagnostic for SLE. (from OMIM and Swiss-Prot) ( NCI )] (UMLS (NCI) C1337055) Small Nuclear Ribonucleoprotein Particle Structural Core Protein;
snRNP Structural Core Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 58. SMALL KIDNEY NOS
- [ ] (UMLS (ICD9CM) C0156247) =Finding
|
- 9. Sm Protein F
- [Small Nuclear Ribonucleoprotein Polypeptide F, encoded by the SNRPF gene, belongs to the snRNP Sm proteins family. This nuclear protein is associated with sn-RNP U1, U2, U4/U6 and U5. The 4 major small nuclear ribonucleoprotein particles (snRNPs), U1, U2, U4/U6, and U5, are essential components of the eukaryotic pre-mRNA splicing machinery. These snRNPs share 8 proteins which form the snRNP structural core: SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF, and SNRPG. These common proteins play an essential role in the biogenesis of the snRNPs. The assembly of the common proteins onto the small nuclear RNA (snRNA) appears to occur in at least 2 steps and involves the formation of RNA-free protein heterooligomers. The common proteins are referred to as Sm proteins because they represent the major targets for the anti-Sm autoantibodies which are diagnostic for SLE. (from OMIM and Swiss-Prot) ( NCI )] (UMLS (NCI) C1367790) Sma;
Small Nuclear Ribonucleoprotein Polypeptide F;
SmF;
Sm-F;
snRNP-F;
SNRPF;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 59. Small Liver Cell Dysplasia
- (UMLS (NCI) C1336010) =Finding ;
|
- 10. SM-5887
- (UMLS (NCI) C0074678) =Organic Chemical; Pharmacologic Substance ;
| - 60. Small Lymphocytic Lymphoma with Plasmacytoid Differentiation
- (UMLS (NCI) C1336012) =Neoplastic Process ;
|
- 11. SM-7338
- (UMLS (NCI) C0740029) =Organic Chemical; Antibiotic
| - 61. small molecule
- [A molecule with a low molecular weight that is not determined by a genome sequence. ( NCI )] (UMLS (CSP) C1328819) =Organic Chemical ;
=Molecular Biology;
molecular size |
- 12. SM-AHNMD
- (UMLS (NCI) C1301365) Systemic Mastocytosis with Associated Clonal Hematological non-Mast-Cell Lineage Disease =Neoplastic Process
| - 62. small nuclear ribonucleoprotein
- [small RNA-protein complexes found in the nucleus that mediate splicing of hnRNP to mRNA by drawing together specific hnRNA sequences to form a loop, which is then excised. ( CSP )] (UMLS (CSP) C0142661) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=spliceosome;
|
- 13. SMAD, Mothers Against DPP Homolog 2 (Drosophila) Gene
- [This gene plays a role in signal transduction and repression of transcription. ( NCI )] (UMLS (NCI) C1334468) SMAD2;
SMAD2 Gene;
=Gene or Genome | - 63. Small Nuclear Ribonucleoprotein Polypeptide F Gene
- [This gene plays a role in nuclear mRNA splicing. ( NCI )] (UMLS (NCI) C1420293) SNRPF;
SNRPF Gene =Gene or Genome |
- 14. SMAD, Mothers Against DPP Homolog 3 (Drosophila) Gene
- [This gene is involved in signal transduction and apoptosis. It also plays a role in the regulation of both steroid synthesis and T-cell response. ( NCI )] (UMLS (NCI) C0919432) SMAD3;
SMAD3 Gene =Gene or Genome ;
| - 64. small nuclear RNA
- [short chains of RNA (100-300 nucleotides long) that are abundant in the nucleus and usually complexed with proteins in small nuclear ribonucleoproteins; many function in the processing of messenger RNA precursors; others, the small nucleolar RNAs, are involved with the processing of ribosomal RNA precursors. ( CSP )] (UMLS (CSP) C0035709) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance =Ribonucleic acid;
|
- 15. SMAD, Mothers Against DPP Homolog 4 (Drosophila) Gene
- [This gene plays a role in signal transduction and transcriptional activation. It is also involved in suppression of angiogenesis. ( NCI )] (UMLS (NCI) C0694891) =Gene or Genome ;
| - 65. Small Plaque Parapsoriasis
- (UMLS (NCI) C0263370) =Disease or Syndrome
|
- 16. SMAD, Mothers Against DPP Homolog 6 (Drosophila) Gene
- [This gene is involved in signal transduction and regulation of transcription. It also plays a role in development. ( NCI )] (UMLS (NCI) C1334469) SMAD6;
SMAD6 Gene =Gene or Genome | - 66. Small RNA
- (UMLS (NCI) C1336014) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance
|
- 17. SMAD, Mothers Against DPP Homolog 7 (Drosophila) Gene
- [This gene plays a role in signal transduction and regulation of transcription. ( NCI )] (UMLS (NCI) C1334470) SMAD7;
SMAD7 Gene =Gene or Genome | - 67. Small Size Posterior Uveal Melanoma
- (UMLS (NCI) C0278867) =Neoplastic Process
|
- 18. SMALL
- [Limited in number, quantity, magnitude or extent. (NCI) ( NCI )] (UMLS (NCI) C0700321) =Quantitative Concept
| - 68. small social group
- [a limited number of individuals, assembled or dispersed, who are united by a common social interest, characteristics or attachment and whose actions are interrelated. ( CSP )] (UMLS (CSP) C0597475) =Social Behavior =social group process;
|
- 19. small airways disease
- [ ] (UMLS (CSP) C0598176) =Disease or Syndrome
| - 69. Small Temporal RNA
- [A class of microRNAs that regulate developmental timing. ( MSH )] (UMLS (NCI) C1136087) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance
|
- 20. small angle X ray scattering
- [ ] (UMLS (CSP) C1537058) =Laboratory Procedure ;
| - 70. Small-to-small intestinal anastomosis
- [ ] (UMLS (ICD9CM) C0192741) =Therapeutic or Preventive Procedure
|
- 21. Small Bowel Excision
- [Surgical removal of part or all of the small intestine. ( NCI )] (UMLS (NCI) C0192601) =Therapeutic or Preventive Procedure
| - 71. smallpox
- [An acute, highly contagious, often fatal infectious disease caused by an orthopoxvirus characterized by a biphasic febrile course and distinctive progressive skin eruptions. Vaccination has succeeded in eradicating smallpox worldwide. (Dorland, 28th ed) ( MSH )] (UMLS (CSP) C0037354) =Disease or Syndrome =Poxviridae disease;
|
- 22. Small bowel necrosis
- (UMLS (NCI) C0748852) Small Bowel Necrosis Adverse Event;
=Finding | - 72. smallpox
- [frequently a live vaccinia virus vaccine of calf lymph or chick embryo origin, used for immunization against smallpox. ( CSP )] (UMLS (HL7) C0037355) =Organic Chemical; Pharmacologic Substance; Immunologic Factor =viral vaccine;
Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType;
|
- 23. SMALL BOWEL SERIES
- [ ] (UMLS (ICD9CM) C0412112) =Diagnostic Procedure
| - 73. SMALLPOX VACCINATION
- (UMLS (ICD9CM) C0042207) =Therapeutic or Preventive Procedure ;
|
- 24. SMALL BOWEL SUTURE NEC
- [ ] (UMLS (ICD9CM) C0176821) =Therapeutic or Preventive Procedure
| - 74. smallpox, diluted
- (UMLS (HL7) C1548470) =Pharmacologic Substance; Immunologic Factor ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
|
- 25. Small Capillary-Sized Vascular Proliferation
- (UMLS (NCI) C1335978) =Finding ;
| - 75. SMARCA1
- [This gene is involved in chromatin remodeling and regulation of transcription. ( NCI )] (UMLS (NCI) C1335840) SMARCA1 Gene;
SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin, Subfamily A, Member 1 Gene;
=Gene or Genome |
- 26. Small Cardiac Vein
- (UMLS (NCI) C0226661) =Body Part, Organ, or Organ Component
| - 76. SMARCA2
- [This gene plays a role in chromatin remodeling and transcriptional activation of genes normally repressed by chromatin. ( NCI )] (UMLS (NCI) C1335841) SMARCA2 Gene;
SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin, Subfamily A, Member 2 Gene;
=Gene or Genome |
- 27. Small Cell Carcinoma of the Thymus
- [An aggressive, small cell, poorly differentiated thymic neuroendocrine carcinoma, characterized by the presence of a high mitotic rate and numerous apoptotic bodies. — 2005 ( NCI )] (UMLS (NCI) C1335980) Small Cell Carcinoma of Thymus;
Thymic Small Cell Carcinoma;
Thymic Small Cell Carcinoma Neuroendocrine Type;
Thymus Small Cell Carcinoma =Neoplastic Process ;
| - 77. SMARCA4
- [This gene plays a role in chromatin remodeling, cell cycle control and regulation of transcription. ( NCI )] (UMLS (NCI) C1335843) SMARCA4 Gene;
SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin, Subfamily A, Member 4 Gene =Gene or Genome |
- 28. Small Cell Carcinoma of the Ureter
- (UMLS (NCI) C1336878) Small Cell Carcinoma of Ureter;
Ureter Small Cell Carcinoma;
Ureteral Small Cell Carcinoma =Neoplastic Process | - 78. SMARCA5
- [This gene is involved in chromatin remodeling and regulation of transcription. ( NCI )] (UMLS (NCI) C1335844) SMARCA5 Gene;
SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin, Subfamily A, Member 5 Gene =Gene or Genome ◊ [This protein is a member of the SWI/SNF family of proteins. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. This protein is a component of the chromatin remodeling and spacing factor RSF, a facilitator of the transcription of class II genes by RNA polymerase II. It is similar in sequence to the Drosophila ISWI chromatin remodeling protein. ( NCI )] (UMLS (NCI) C1449387) SNF2H; SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin, Subfamily A, Member 5 Amino Acid, Peptide, or Protein; Enzyme |
- 29. Small Cell Carcinoma, Fusiform Cell Type
- [A neuroendocrine carcinoma composed of malignant fusiform small cells. ( NCI )] (UMLS (NCI) C0334238) =Neoplastic Process
| - 79. SMARCB1
- [This gene plays a role in chromatin remodeling and regulation of transcription. ( NCI )] (UMLS (NCI) C0812273) SMARCB1 Gene;
SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily B, Member 1 Gene;
=Gene or Genome |
- 30. Small Cell Carcinoma, Intermediate Cell
- [A neuroendocrine carcinoma composed of malignant small cells of intermediate shape. ( NCI )] (UMLS (NCI) C0334239) =Neoplastic Process
| - 80. SMARCC1
- [This gene plays a role in chromatin remodeling and regulation of transcription. ( NCI )] (UMLS (NCI) C1335845) SMARCC1 Gene;
SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin, Subfamily C, Member 1 Gene =Gene or Genome |
- 31. Small Cell Osteogenic Sarcoma
- [An osteosarcoma usually arising from the metaphysis of long bones. It is characterized by the presence of small cells and osteoid production. The prognosis is usually unfavorable. ( NCI )] (UMLS (NCI) C0279622) =Neoplastic Process
| - 81. SMARCC2
- [This gene is involved in chromatin remodeling and regulation of transcription. ( NCI )] (UMLS (NCI) C1335846) SMARCC2 Gene;
SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin, Subfamily C, Member 2 Gene =Gene or Genome |
- 32. Small Cell Salivary Gland Carcinoma
- (UMLS (NCI) C1335982) Small Cell Undifferentiated Salivary Gland Carcinoma;
=Neoplastic Process ;
| - 82. SMARCD1
- [This gene plays a role in chromatin remodeling and regulation of transcription. ( NCI )] (UMLS (NCI) C1335847) SMARCD1 Gene;
SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily D, Member 1 Gene =Gene or Genome |
- 33. Small Cell Undifferentiated Hepatoblastoma
- [A hepatoblastoma composed exclusively of noncohesive sheets of small undifferentiated cells. ( NCI )] (UMLS (NCI) C1335981) =Neoplastic Process ;
| - 83. SMARCD2
- [This gene plays a role in chromatin remodeling and regulation of transcription. ( NCI )] (UMLS (NCI) C1335848) SMARCD2 Gene;
SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin, Subfamily D, Member 2 Gene =Gene or Genome |
- 34. Small Cell Variant Anaplastic Large Cell Lymphoma
- (UMLS (NCI) C1335983) =Neoplastic Process ;
| - 84. SMARCD3
- [This gene is involved in chromatin remodeling and regulation of transcription. ( NCI )] (UMLS (NCI) C1335849) SMARCD3 Gene;
SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily D, Member 3 Gene =Gene or Genome |
- 35. Small Children Dependent
- (UMLS (HL7) C1546851) =Idea or Concept =Living Dependency;
| - 85. SMARCE1
- [This gene is involved in chromatin remodeling and regulation of transcription. ( NCI )] (UMLS (NCI) C1335850) SMARCE1 Gene;
SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily E, Member 1 Gene =Gene or Genome ;
|
- 36. Small Cleaved Follicle Center Cell
- [A lymphoid cell of follicular center cell origin that has an irregularly shaped nucleus with clumped chromatin, absent nucleoli, and one or more clefts in the nuclear membrane. ( NCI )] (UMLS (NCI) C0333855) =Cell
| - 86. Smear, Tzanck
- (UMLS (HL7) C1547938) =Intellectual Product =Specimen Source Codes;
|
- 37. Small G Protein
- [A class of small GTP-binding regulatory proteins regulated by G protein coupled receptors that act as switches in signal transduction pathways. The nature of the nucleotide bound to the protein determines its activity: GTP in the active state, GDP in the inactive state. The prototype for this class of proteins is the cellular proto-oncogene RAS. ( NCI )] (UMLS (NCI) C0751984) =Amino Acid, Peptide, or Protein; Enzyme
| - 87. smegma
- [A white secretion of the sebaceous glands of the foreskin. ( NCI )] (UMLS (CSP) C0037359) =Body Substance
|
- 38. Small Intestinal Crypt of Lieberkuhn
- (UMLS (NCI) C0227267) =Body Part, Organ, or Organ Component
| - 88. Smell
- (UMLS (HL7) C1547044) =Quantitative Concept =Kind of quantity;
|
- 39. Small Intestinal Dysplasia
- (UMLS (NCI) C1335999) Small Intestinal Intraepithelial Neoplasia =Neoplastic Process
| - 89. Smith Magenis syndrome
- [a rare chromosomal disorder characterized by abnormalities of the craniofacial area (brachycephaly, prognathism, cleft palate), delays in the acquisition of skills requiring the coordination of mental and muscular activities, mental retardation; most affected individuals experience speech delays that may occur in association with hearing impairment; behavioral abnormalities may include hyperactivity and self-destructive behavior. ( CSP )] (UMLS (CSP) C0795864) =Disease or Syndrome ;
=Chromosomal anomalies;
Arrieration mentale;
syndrome;
congenital oral/facial/cranial defect |
- 40. Small Intestinal EC-Cell Serotonin Producing Tumor
- (UMLS (NCI) C1335993) =Neoplastic Process ;
| - 90. Smith River
- (UMLS (HL7) C1551912) Tolowa;
=Language =OregonAthapaskan;
|
- 41. Small Intestinal Gastrin Producing Neoplasm
- (UMLS (NCI) C1335995) Small Intestinal Gastrin Producing Tumor =Neoplastic Process
| - 91. Smith River Rancheria, California
- (UMLS (HL7) C1554497) =Population Group =NativeEntityContiguous;
|
- 42. Small Intestinal High Grade Intraepithelial Neoplasia
- (UMLS (NCI) C1335997) Small Intestinal High-Grade Dysplasia =Neoplastic Process
| - 92. SmithKline Beecham
- [SmithKline Beecham ( HL7V3.0 )] (UMLS (HL7) C1552903) =Health Care Related Organization ;
=VaccineManufacturer;
|
- 43. Small Intestinal L-Cell Glucagon-Like Peptide Producing Neoplasm
- (UMLS (NCI) C1336000) Small Intestinal L-Cell Glucagon-Like Peptide Producing Tumor =Neoplastic Process
| - 93. SMO
- [This gene plays a role in G protein-coupled receptor signal transduction and sonic hedgehog pathway activation. ( NCI )] (UMLS (NCI) C1364142) SMO Gene;
Smoothened Homolog (Drosophila) Gene =Gene or Genome ;
|
- 44. Small Intestinal Low Grade Intraepithelial Neoplasia
- (UMLS (NCI) C1336002) Small Intestinal Low-Grade Dysplasia =Neoplastic Process
| - 94. smog
- [A mixture of smoke and fog polluting the atmosphere. (Dorland, 27th ed) ( MSH )] (UMLS (CSP) C0037365) =Natural Phenomenon or Process
|
- 45. Small Intestinal Mucosa
- [Mucosa arranged into two fundamental structures - villi and crypts of Lieberkuhn. Villi are projections into the lumen of the small intestine, covered with simple columnar epithelium. Crypts of Lieberkuhn are moat-like invaginations of the epithelium around the villi that extend through the lamina propria down to the muscularis mucosae. Lymphocytes often invade the epithelium or form solitary lymphoid nodules in the lamina propria. Lymph nodules may form longitudinal aggregations of 30-50 nodules in the lamina propria of the ileum. These large aggregations are called Peyer's patches. The muscularis mucosae has two layers and extends into the intestinal villi, where the smooth muscle cells form a longitudinal bundle in the centre of the villi. The small intestinal mucosa secretes gastrin, somatostatin, cholecystokinin and secretin. ( NCI )] (UMLS (NCI) C0227261) =Tissue
| - 95. Smoke
- [Smoke from burning tobacco (cigarettes, cigars, or pipes) and exhaled by a smoker. Tobacco smoke contains nicotine, a stimulant, and other biologically active chemicals having carcinogenic properties. ( NCI )] (UMLS (NCI) C0439994) =Hazardous or Poisonous Substance ;
|
- 46. Small Intestinal Muscular Coat
- [Muscular coat consisting of two layers of smooth muscle - an external, longitudinal, and an internal, circular layer. The longitudinal fibers are thinly scattered over the surface of the small intestine, and are more distinct along its free border. The circular fibers form a thick, uniform layer, and are composed of plain muscle cells of considerable length. The muscular coat is thicker at the upper than at the lower part of the small intestine. Interstitial cells of Cajal are present in the small intestinal muscular coat. ( NCI )] (UMLS (NCI) C0227269) =Tissue
| - 96. smoke inhalation
- [Pulmonary injury following the breathing in of toxic smoke from burning materials such as plastics, synthetics, building materials, etc. This injury is the most frequent cause of death in burn patients. ( MSH )] (UMLS (CSP) C0037367) =Injury or Poisoning =Burns, Inhalation;
gas poisoning |
- 47. Small Intestinal Muscularis Mucosa
- [Two-layered muscularis mucosa extending into the small intestinal villi, where the smooth muscle cells form a longitudinal bundle in the centre of the villi. It is located between the lamina propria and submucosa of the small intestine. ( NCI )] (UMLS (NCI) C0227262) =Tissue
| - 97. smokeless tobacco
- [tobacco whose use does not produce smoke; associated with increased risk of oral cancer. ( CSP )] (UMLS (CSP) C0040338) =Substance =TOBACCO;
Abuso de tabaco |
- 48. Small Intestinal Neuroendocrine Neoplasm
- (UMLS (NCI) C1336005) Small Intestine Neuroendocrine Neoplasm;
Small Intestine Neuroendocrine Tumor =Neoplastic Process | - 98. Smokers Keratosis
- (UMLS (NCI) C0399478) =Disease or Syndrome
|
- 49. Small Intestinal Poorly Differentiated Endocrine Neoplasm
- (UMLS (NCI) C1336008) Small Intestinal Small Cell Carcinoma;
=Neoplastic Process | - 99. smoking
- [to inhale and exhale the smoke produced by the combustion of a substance. ( CSP )] (UMLS (CSP) C0037369) =Individual Behavior =drug administration route;
|
- 50. Small Intestinal Somatostatin Producing Neoplasm
- (UMLS (NCI) C1335992) Small Intestinal Somatostatin Producing Tumor =Neoplastic Process ;
| - 100. Smoking
- (UMLS (HL7) C1548578) =Intellectual Product =Location characteristic ID;
|
home
